Author:
Pircher Andreas,Steiner Normann,Gunsilius Eberhard
Publisher
Springer International Publishing
Reference121 articles.
1. Addeo R, Sgambato A, Cennamo G, Montella L, Faiola V, Abbruzzese A, Capasso E, Leo L, Botti G, Caraglia M, Del Prete S (2010) Low-dose metronomic oral administration of vinorelbine in the first-line treatment of elderly patients with metastatic breast cancer. Clin Breast Cancer 10(4):301–306. doi:
10.3816/CBC.2010.n.039
2. Bandyopadhyay A, Das M, Kundu SK (2014) Metastatic primary duodenal adeno-carcinoma responding to metronomic oral cyclophosphamide chemotherapy. Indian J Palliat Care 20(3):239–242. doi:
10.4103/0973-1075.138402
3. Banys-Paluchowski M, Schütz F, Ruckhäberle E, Krawczyk N, Fehm T (2016) Metronomic chemotherapy for metastatic breast cancer – a systematic review of the literature. Geburtshilfe Frauenheilkd 76(5):525–534. doi:
10.1055/s-0042-105871
4. Barroso-Sousa R, da Fonseca LG, Souza KT, Chaves AC, Kann AG, de Castro G Jr, Dzik C (2015) Metronomic oral cyclophosphamide plus prednisone in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer. Med Oncol 32(1):443. doi:
10.1007/s12032-014-0443-4
5. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2(11):1843–1849